🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
The purpose of this study is to assess the pharmacokinetics of the combinat...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-11
Trial ID
NCT01363037
The objective of this study was to estimate the effects of a single dose of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00853840
Treatments Being Tested
The IMPACT Long Covid Treatment clinical study (IMPACT-LC) is testing two r...
Status
Not Yet Recruiting
Location
University of Arizona
Start Date
2026-07-15
Trial ID
NCT06974084
Treatments Being Tested
First in human study to evaluate the safety, tolerability, and pharmacokine...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-10
Trial ID
NCT00783484
The purpose of this study is to assess whether maraviroc administered once ...
Status
Terminated
Location
University of Alabama at Birmingham - 1917 Research Clinic
Start Date
2011-09
Trial ID
NCT01345630
Rationale: Improving cellular immunity by means of increasing CD4 cells is ...
Status
Completed
Location
Onze Lieve Vrouwe Gasthuis
Start Date
2009-02
Trial ID
NCT00875368
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Mills Clinical Research
Start Date
2017-05-09
Trial ID
NCT03060447
Treatments Being Tested
The main purpose of this study was to compare the effects on bones of the f...
Status
Completed
Location
31788 Alabama CRS
Start Date
2012-01-17
Trial ID
NCT01400412
This study will evaluate the efficacy of switching from emtricitabine/tenof...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-05-06
Trial ID
NCT02121795
Treatments Being Tested